RecruitingPhase 2NCT06191198

Communication Bridge 3 Study

Communication Bridge: Optimizing an Evidence-based Intervention for Individuals With Primary Progressive Aphasia


Sponsor

University of Chicago

Enrollment

200 participants

Start Date

Aug 23, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

This study will use a randomized controlled trial design to evaluate the effect of two evidence-based treatments for adults with mild-moderate Primary Progressive Aphasia (PPA). The aim of the study is to help us better understand the effects of speech-language therapy on communication abilities in individuals with PPA.


Eligibility

Min Age: 18 YearsMax Age: 100 Years

Plain Language Summary

Simplified for easier understanding

This study is testing a digital communication support program called Communication Bridge for people with Primary Progressive Aphasia (PPA) — a brain condition that progressively affects the ability to speak, read, and write — and their communication partners. **You may be eligible if...** - You have been diagnosed with mild-to-moderate Primary Progressive Aphasia - English is your main language for daily communication - You have adequate hearing and vision (with or without aids) - You are comfortable using video calling technology (or willing to learn) - You have a communication partner (such as a family member) who can join the study with you **You may NOT be eligible if...** - You have a dementia diagnosis other than Primary Progressive Aphasia - You are currently enrolled in a separate speech-language therapy program - Your depression score is too high (above 9 on the Geriatric Depression Scale) Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALCommunication Bridge™

Evidence-based speech language therapy treatment will be compared and contrasted in the two arms of the study.

BEHAVIORALEvidence-Based Impairment Focused

Evidence-based speech language therapy treatment will be compared and contrasted in the two arms of the study.


Locations(1)

University of Chicago - American School Building

Chicago, Illinois, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06191198


Related Trials